Karuna Therapeutics, Inc.

FARALLON CAPITAL MANAGEMENT LLC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

2,200

Value ($000)

372

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	372	0.0%	2,200	9/30/2023
2023 Q2	8/14/2023	477	0.0%	2,200	6/30/2023
2023 Q1	5/15/2023	400	0.0%	2,200	3/31/2023
2022 Q4	2/14/2023	432	0.0%	2,200	12/31/2022
2022 Q3	11/14/2022	17,994	0.1%	80,000	9/30/2022
2022 Q2	8/15/2022	12,651	0.1%	100,000	6/30/2022
2022 Q1	5/16/2022	44,377	0.3%	350,000	3/31/2022
2021 Q4	2/14/2022	72,050	0.4%	550,000	12/31/2021
2021 Q3	11/15/2021	85,631	0.5%	700,000	9/30/2021
2021 Q2	8/13/2021	71,814	0.4%	630,000	6/30/2021
2021 Q1	5/17/2021	81,155	0.5%	675,000	3/31/2021
2020 Q4	2/16/2021	71,113	0.5%	700,000	12/31/2020
2020 Q3	11/16/2020	54,124	0.4%	700,000	9/30/2020
2020 Q2	8/14/2020	64,090	0.5%	575,000	6/30/2020
2020 Q1	5/15/2020	40,827	0.4%	567,047	3/31/2020
2019 Q4	2/13/2020	45,204	0.4%	600,000	12/31/2019